◆英語タイトル：Synthetic Biologics Inc (SYN) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is intended to treat rritable bowel syndrome with constipation. Synthetic Biologics’ SYN-004 is an oral prophylactic therapy for prevention of clostridium difficile infection, pathogenic overgrowth and the emergence of antimicrobial resistance. It develops preclinical monoclonal antibody therapies for the treatment of pertussis, and novel discovery stage biotherapeutics for the treatment of phenylketonuria. The company undertakes various research activities to develop therapeutics. It collaborates with various academic and pharmaceutical companies to develop its product candidates. Synthetic Biologics is headquartered in Rockville, Maryland, the US.
Synthetic Biologics Inc Key Recent Developments
Mar 04,2021: Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results
Feb 25,2021: Synthetic Biologics to Report 2020 Year End Operational Highlights and Financial Results on March 4, 2021
Nov 24,2020: Synthetic Biologics announces extension of compliance plan period by NYSE American
Nov 16,2020: Synthetic Biologics engages A.G.P./Alliance Global Partners as advisor to assist in evaluating strategic options
Nov 12,2020: Synthetic Biologics welcomes senior biotech executive John Monahan, PhD, to Board of Directors
This comprehensive SWOT profile of Synthetic Biologics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Synthetic Biologics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Synthetic Biologics Inc – Key Information
Synthetic Biologics Inc – Overview
Synthetic Biologics Inc – Key Employees
Synthetic Biologics Inc – Key Employee Biographies
Synthetic Biologics Inc – Key Operational Heads
Synthetic Biologics Inc – Major Products and Services
Synthetic Biologics Inc – History
Synthetic Biologics Inc – Company Statement
Synthetic Biologics Inc – Locations And Subsidiaries
Synthetic Biologics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Synthetic Biologics Inc – Business Description
Synthetic Biologics Inc – Corporate Strategy
Synthetic Biologics Inc – SWOT Analysis
SWOT Analysis – Overview
Synthetic Biologics Inc – Strengths
Synthetic Biologics Inc – Weaknesses
Synthetic Biologics Inc – Opportunities
Synthetic Biologics Inc – Threats
Synthetic Biologics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Synthetic Biologics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Synthetic Biologics Inc, Key Information
Synthetic Biologics Inc, Key Ratios
Synthetic Biologics Inc, Share Data
Synthetic Biologics Inc, Major Products and Services
Synthetic Biologics Inc, History
Synthetic Biologics Inc, Key Employees
Synthetic Biologics Inc, Key Employee Biographies
Synthetic Biologics Inc, Key Operational Heads
Synthetic Biologics Inc, Other Locations
Synthetic Biologics Inc, Subsidiaries
Synthetic Biologics Inc, Key Competitors
Synthetic Biologics Inc, SWOT Analysis
Synthetic Biologics Inc, Ratios based on current share price
Synthetic Biologics Inc, Annual Ratios
Synthetic Biologics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Synthetic Biologics Inc (SYN)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら